BIOCORP Announces Its Participation in Several Conferences and Congresses
23 März 2022 - 7:30AM
Business Wire
Regulatory News:
BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR),
a French company specialized in the design, development, and
manufacturing of innovative medical devices, presents its agenda of
investor meetings and professional conventions in the next few
weeks.
- March 23 & 24, 2022 - French-speaking Diabetes Society
(SFD) Congress in Nice (France): Mallya presentation on our
partners’ booth Sanofi and Roche Diabetes Care France.
- April 5, 2022 – Investor Access in Paris (France) :
Management will present the 2021 annual financial results and the
2022 outlook to investors.
- April 27 to 30, 2022 – 15th ATTD (Advanced Technologies
& Treatments for Diabetes) conference in Barcelona
(Spain): BIOCORP will talk about its latest technological advances
concerning Mallya.
- May 16 & 17, 2022 – PDA Medical Devices and Connected
Health Conference in Dublin (Ireland): presentation by
Arnaud Guillet (Vice-President Business Development of BIOCORP):
“Connected drug delivery devices - Roadmap from commercial pilots
to mass adoption, use cases in different regions of the world
“.
- May 18 & 19, 2022 - Biocorp booth at Pharmapack Europe
in Paris (France), the European hub of drug delivery devices
industry.
ABOUT BIOCORP
Recognized for its expertise in the development and manufacture
of medical devices and delivery systems, BIOCORP has today acquired
a leading position in the connected medical device market thanks to
Mallya. This smart sensor for insulin injection pens allows
reliable monitoring of injected doses and thus offers better
compliance in the treatment of patients with diabetes. Available
for sale from 2020, Mallya spearheads BIOCORP's product portfolio
of innovative connected solutions. The company has 70 employees.
BIOCORP is listed on Euronext since July 2015 (FR0012788065 –
ALCOR).
For more information, please visit www.biocorpsys.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220322005922/en/
BIOCORP Jacques Gardette Chairman of the Board
investisseurs@biocorp.fr
Éric Dessertenne Chief Executive Officer
Sylvaine Dessard Marketing & Communication Director
rp@biocorp.fr + 33 (0)6 88 69 72 85
CONTACTS ULYSSE COMMUNICATION Bruno ARABIAN
barabian@ulysse-communication.com +33 (0)6 87 88 46 26
Nicolas DANIELS ndaniels@ulysse-communication.com +33 (0)6 63 66
59 22
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Apr 2023 bis Apr 2024